bullish•Life360 Inc•05 Mar 2023 09:00
S&P/ASX Index Rebalance (Mar 2023): Big Impact Changes as Adds Outperform Deletes
There are 19 adds and 16 deletes across the S&P/ASX family of indices. On the larger names, passives need to buy 7-20x ADV while selling between 1...
bullish•Ebos Group Ltd•05 Apr 2022 21:53
EBOS Group (EBO NZ): Strong Industry Positioning and Acquisitions to Drive Growth
EBOS is an attractive bet on Australasian healthcare space, due to enhanced visibility of its accretive acquisition of LifeHealthcare and continued...
bullish•Canon Inc•02 Apr 2022 23:15
Sticking With Cyclical Value and Defensives; Adding Large-Cap Japan Technology
Sticking With Cyclical Value & Defensives; Adding Large-Cap Japan Technology. 2-3 week bounce has likely run its course with $TOPIX $Nikkei 225,...
bullish•Australian Pharmaceutical Industries•16 Feb 2022 16:10
Aussie Pharma (API AU): Scheme Booklet Out. Meeting On The 17 March
Trading super at a gross/annualised spread of 0.3%/2.8%. However, if you are a low-rate payer, who can reclaim the franking credits, there's may...
bullish•Ebos Group Ltd•16 Dec 2021 17:14